| Name | Walgreens #7908 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 27130 172nd Ave Se, Covington, Washington 98042 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (253) 630-6791 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have major drawbacks, but a team from The Scripps Research Institute (TSRI) has demonstrated a new technique that may lead to a better way to selectively repress unwanted immune reactions without disabling the immune system as a whole.
As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus.
Australian pharmaceutical company Pharmaxis Ltd and UK biotechnology company Synairgen plc today announced they have entered into a research collaboration to develop a selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) to treat the fatal lung disease idiopathic pulmonary fibrosis (IPF).
Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa's meningitis belt. Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides, the news service writes, noting the effort is the culmination of ten years' work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.
› Verified 6 days ago
| NPI Number | 1750398673 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #07908 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 27130 172nd Ave Se, Covington, WA 98042 |
| Phone Number | 253-630-6791 |
News Archive
The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have major drawbacks, but a team from The Scripps Research Institute (TSRI) has demonstrated a new technique that may lead to a better way to selectively repress unwanted immune reactions without disabling the immune system as a whole.
As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus.
Australian pharmaceutical company Pharmaxis Ltd and UK biotechnology company Synairgen plc today announced they have entered into a research collaboration to develop a selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) to treat the fatal lung disease idiopathic pulmonary fibrosis (IPF).
Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa's meningitis belt. Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides, the news service writes, noting the effort is the culmination of ten years' work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.
› Verified 6 days ago
News Archive
The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have major drawbacks, but a team from The Scripps Research Institute (TSRI) has demonstrated a new technique that may lead to a better way to selectively repress unwanted immune reactions without disabling the immune system as a whole.
As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus.
Australian pharmaceutical company Pharmaxis Ltd and UK biotechnology company Synairgen plc today announced they have entered into a research collaboration to develop a selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) to treat the fatal lung disease idiopathic pulmonary fibrosis (IPF).
Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa's meningitis belt. Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides, the news service writes, noting the effort is the culmination of ten years' work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.
› Verified 6 days ago
Proliance Orthopedic Associates Type: Medicare Supplier Location: 27005 168th Pl Se, Covington, Washington 98042 Phone: (253) 630-3660 | |
Safeway Pharmacy #0792 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17023 Se 272nd St, Covington, Washington 98042 Phone: (253) 631-2450 | |
Rite Aid Pharmacy 05198 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17125 Se 272nd St, Covington, Washington 98042 Phone: (253) 630-9880 | |
Walgreens #7908 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 27130 172nd Ave Se, Covington, Washington 98042 Phone: (253) 630-6791 | |
Walmart Pharmacy 10-5073 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17432 Se 270th Pl, Covington, Washington 98042 Phone: (253) 630-8682 |